1. Podcasts
  2. 1A
  3. Behind The Dramatic Drop In Overdose Deaths
1A

19 Jun 2025 · 33m · 19 chapters

Episode artwork

Behind The Dramatic Drop In Overdose Deaths

In short

The episode explains why US overdose deaths fell sharply in 2024 (CDC: largest one-year decline, about 27%, with fewer deaths in every state except two) after decades of opioid-driven increases, and what risks federal funding cuts could pose. It also discusses harm reduction, changes in the drug supply (fentanyl plus sedatives like xylazine, benzodiazepines; Philadelphia shifting from xylazine to metatomidine), and how opioid settlement money is being used.

Guests

Nabaroon Dasgupta, street drug scientist (UNC) and co-founder of Remedy Alliance for the People, which helps harm reduction programs access low-cost naloxone. Kaylee McLeod, director of Philadelphia’s city-run overdose response unit. Aneri Patani, senior correspondent at KFF Health News covering mental health and addiction.

Key claims

Fewer deaths doesn’t prove fewer overdoses; naloxone access and local “invisible work” likely contributed; demographic disparities persist (lowest drop among Black older men; Philly Black males median age 52). Federal cuts (e.g., $11B mental health/addiction grant cancellation) may weaken “last-mile” outreach and treatment access.

Notable examples

Philadelphia canvassing (Oct 2023) distributing 33,000 naloxone doses and 36,000 fentanyl test strips in Black and brown neighborhoods; listener stories; Colorado peer-recovery program Hard Beauty; Purdue Pharma/OxyContin settlement ($7.4B agreed by 50 states + DC + four territories, still in court).

Written by AI. May contain mistakes.

Chapters

0:00

Rise and Recent Decline of Overdose Deaths

Learn about the significant decline in drug overdose deaths in the US and contributing factors.

“Drug overdose deaths in the US increased steadily for over two decades, in large part due to opioids.”
2:25

Understanding the CDC Data

Dive into CDC statistics on overdose deaths and their implications.

“She's the director of Philadelphia's city-run overdose response unit.”
4:25

Demographic Impact of the Opioid Crisis

Explore the demographic shifts and their effects on overdose statistics.

“but Aneri, in your reporting, what else do you think we need to understand about the current state of the opioid epidemic today?”
6:17

Philadelphia's Approach to Overdose Prevention

Learn about unique initiatives in Philadelphia to combat overdose deaths.

“Now, Kaylee, you mentioned Philadelphia and the fact that black men, middle-aged black men, are still suffering greatly from overdose deaths.”
8:02

The Shift in Conversations Around Drug Use

Discuss the evolving narrative and societal response to drug use and overdose.

“We started a canvassing program in October 2023.”
9:46

The Silent Crisis in Overdose Deaths

Understand the overlooked overdose crisis in various communities.

“And a lot of that, they will attribute to the demographics of who was involved, right?”
11:40

Changing Landscape of Drug Types

Examine how the types of drugs involved in the epidemic have evolved.

“a silent crisis present in other communities that just went overlooked?”
13:16

Impact of New Substances on Overdose Rates

Learn how new substances like xylazine are affecting overdose responses.

“And I think that that's one of the things that's really important, that what was driving so much of this huge increase in fatal overdose that we saw is not necessarily that more people were using drugs, right?”
14:00

The Shift in Drug Composition and Overdose Implications

Learn about the changing landscape of street drugs and their effects on overdose rates.

“of xylosine in the drug supply, which is a veterinary tool that is actually not safe for human consumption.”
16:20

Harm Reduction Strategies in New Hampshire and Philadelphia

Explore how harm reduction strategies are being implemented in New Hampshire and Philadelphia.

“Still to come, the Trump administration makes big changes to mental health and drug programs.”
Show all 19 chapters
18:12

The Role of Empathy in Addressing Overdose Issues

Understand the importance of empathy in community responses to the overdose crisis.

“to expand our continuum and make sure that these resources are really available for everybody that needs them when they need them.”
19:32

The Need for Effective Education and Prevention

Discover the necessity for improved education to combat drug use and overdose deaths.

“She's the director of Philadelphia's city-run overdose response unit.”
21:10

Federal Funding Initiatives and Policy Changes

Learn about recent federal funding initiatives and their impact on addiction services.

“Aniri, what sort of programs and funding did the Biden administration specifically put in place to combat the opioid epidemic?”
23:49

Concerns Over Cuts to Addiction Services

Examine the potential consequences of funding cuts on addiction recovery services.

“What other funding could be on the chopping block?”
25:05

The Opioid Settlement Funds and Their Distribution

Gain insights into opioid settlement funds and their intended use for addiction treatment.

“I think exactly what Aneri just said of we're losing our last mile capability.”
28:00

Understanding Opioid Settlements

Learn how opioid settlement funds are allocated and their impact on victims.

“There's so much frustration and confusion because when people hear opioid settlements, they assume, you know, the victims of the crisis, the individuals, the families are getting payouts.”
29:06

Impact of Research Funding Cuts

Explore how cuts to research funding affect understanding of addiction treatment.

“Well, and number one, I'm curious about the research aspect of this.”
30:18

Focus Areas for Communities

Identify key areas for community focus in combating the opioid crisis.

“continues to combat the opioid crisis, what do you think are some key things for communities to continue to focus on, things that are working?”
31:26

Federal Cuts and Settlement Funds

Discuss the implications of federal funding cuts in relation to settlement funds.

“Aneri, what are you watching either at the federal level or around what happens with these settlement funds?”
A man walking through an airport, asking his phone a question

Ask about this episode

Get the gist, explore an idea or ask about something said.

Claude

On 1A, what are the key points of this episode?

Searching your listening

Transcript

Automatic transcript. May contain errors.

0:07Drug overdose deaths in the US increased steadily for over two decades, in large part due to opioids. That's until recently. New data from the CDC found that 2024 saw the largest one-year decline ever recorded, and that 27 % drop was felt across the country. Every state except two saw fewer overdose deaths. The drop comes after an aggressive public health response from the Biden administration and local efforts, which made the overdose reversal drug naloxone more accessible. Opioid settlement funds have also made their way to states, as drug companies are held responsible for fueling deaths. This week, 50 states, along with the District of Columbia and four U.S.

0:48territories, agreed to a$7.4 billion settlement with Purdue Pharma, which sold and marketed OxyContin. But the crisis is far from over. Drug overdose deaths are still the leading cause of death for people aged 18 to 44. We heard from some of you who have been affected. I am a mother of three after losing my 19-year-old son in November of 2021 to fentanyl overdose. And since then, I have created a small nonprofit to provide support and education to young people in the prevention of this devastating loss. Thank you for sharing your story with us. In March, the Trump administration abruptly canceled over$11 billion in grants funding mental health and addiction treatment programs aimed at reducing overdose deaths.

1:42That has a lot of people worried about what will happen to the tools that have helped reverse the epidemic's trend. What can we learn from looking at the recent decline in drug deaths? And what could federal cuts mean for that progress? We take a closer look after this short break. I'm Jen White. You're listening to the 1A Podcast. Back with our conversation in a moment.

2:05Let's meet our panel. Joining us now is Nabaroon Dasgupta. He's a street drug scientist at the University of North Carolina with two decades of experience in overdose prevention. He's also the co-founder of Remedy Alliance for the People, which ensures harm reduction programs have access to low-cost naloxone. Nabaroon, welcome. Thanks for having me. Also with us is Kaylee McLeod. She's the director of Philadelphia's city-run overdose response unit. Kaylee, welcome back to the program. Thank you. And Aneri Patani, a senior correspondent at KFF Health News covering mental health and addiction. Aneri, it's always great to have you with us.

2:42Glad to be here. Now, Bruin, let's first dig a bit more into these numbers from the CDCs. What are the top line figures that stand out for you? So we're down about 30 % from where overdoses peaked in the United States. This is a historic decline after, like you said, decades of increase. Kaylee, what don't these numbers tell us? Sure. I think it's really important that we recognize that fatal overdose is only one data point. And it doesn't necessarily mean that less people are experiencing overdose. It means that less people are dying from overdose. We also know that non-fatal overdose, which may be a better way to measure sort of society's health is incredibly hard to measure as many people that experience overdose don't go to the emergency department or call EMS.

3:36And so just to be clear, it's not, we don't know for sure that fewer people are overdosing. We know that fewer people are dying from overdosing. Is that correct? Yes, absolutely. And I think the other thing that is important about the data is number one, we want to celebrate all lives that are saved. This is a historic drop as Dr. Dasgupta and yourself mentioned. But we also know that this drop is not equal across different demographics. And in fact, we saw the lowest drop amongst black older men. And in the city of Philadelphia, black males are still the demographic with the highest number of fatal overdose with a median age of 52.

4:22I want to talk a little bit more about that stat in a second, but Aneri, in your reporting, what else do you think we need to understand about the current state of the opioid epidemic today? I mean, I think what Kaylee said is really important in that, you know, it's great to see overdose deaths come down, but there are a lot of other metrics to look at, non-fatal overdoses, but also how many people are dealing with addiction, trying to get into treatment but can't, either because there's not availability or they can't afford it? How many family members are affected, right? Addiction is not just affecting the individual.

4:54It's a family and a community disease. What happens to children who are born into families that are dealing with chaotic substance use? So I think there's a lot of different tentacles of the problem. And we look at the one that's sort of easiest to measure, easiest to report. And it's great to see some progress there. But if you talk to folks who have been personally affected, they would kind of point to all these other things we need to be looking at and measuring and seeing if we're making progress there too. Well, Nebarun, we talked about naloxone and its availability, how that may be preventing or playing a big role in preventing overdose deaths.

5:28But what are some other reasons we should examine as a possible explanation for this drug? So I think there's also been a demographic shift in who's using opioids. We see the Gen Z, for example, not initiating opioid use in the same way as their parents or their grandparents' generations are. And we also see changes in the drug supply. There are additional additives, additional kind of things that are being put in with fentanyl that change the fundamental profile of how likely someone is to overdose. But I think really at the heart of it is that there are so many community groups that have done so much work, kind of what I call invisible work, happening quietly in every county, every city.

6:16And those collective efforts have to be making a substantial difference locally. Now, Kaylee, you mentioned Philadelphia and the fact that black men, middle-aged black men, are still suffering greatly from overdose deaths. What efforts has Philly made to combat the opioid epidemic? Sure. You know, I think that it's a little bit complicated and complex because we really want to look to some of the history around our response to drug use to really understand, I think, a key part of this. So when we have older black men, median age 52, if you play the tape backwards to where these men were about 30 years ago, you're really going to find yourself in so much of that very heavy war on drugs, super predator, really overly harsh punitive measures related to substance use, whether possession or use.

7:15And so to me, it makes tons of sense then that this is the demographic that is very unlikely to proactively raise their hand in public, access resources, come up to the table where we're handing out resources. And for so long, the message has really been carrying naloxone if you use drugs or if you love somebody who uses drugs. But that really relies on the fallacy that we know who is using drugs. So what the city of Philadelphia really was thinking about was how do we get these resources out without requiring people to self-identify and somewhat out themselves as a person who uses drugs. So in this city, we decided to give it to everybody.

8:04We started a canvassing program in October 2023. And this is specifically in black and brown neighborhoods where we're experiencing increasing rates of overdose. And we are knocking on every single door and handing out naloxone and fentanyl test strips, as well as the ability to get somebody immediately into treatment if they need it. So far, to date, the canvassers have distributed over 33 ,000 doses of naloxone and over 36 ,000 fentanyl test strips, specifically in black and brown neighborhoods. And so are you starting to see that program gain traction? Are you starting to see any impact on the numbers at this point?

8:51So I think, as Dr. Dasgupta said, it's kind of hard to measure, right? because, and the other thing is, is we don't wanna necessarily go back to people and ask if they've used it because we know that these are communities in which people have been historically overly surveilled. But we have heard anecdotally that this is working and there are quite a number of other jurisdictions that have adopted similar canvassing programs, specifically in black and brown neighborhoods. Aneri, it makes me wonder whether we've seen a shift in the conversation around criminalizing drug use in recent years and whether there is a connection between perhaps a shift around stigma or laws criminalizing drug use that may also align with some of what we're hearing from the CDC around a drop in drug overdose deaths?

9:45I think a little bit of all of what you said, I think when I speak to folks there who've had been in this work for a long time, they will say, if you look at the societal governmental response to the crack epidemic versus the opioid epidemic, you'll see a very different response. And a lot of that, they will attribute to the demographics of who was involved, right? With the crack epidemic, you had a lot of Black Americans. And with the opioid epidemic, when it started, you saw a lot of white suburban American families affected. And so that sort of shifted the conversation. people responded to the opioid epidemic with more of a health lens and a compassionate lens.

10:24Now, as we see the demographics of who's using opioids or overdosing changing back to a lot of, you know, middle-aged Black men, I think a lot of folks are hoping that that, you know, treatment, compassionate approach is retained. And we see a little bit of back and forth. There are some states that have put forth laws that are more punitive for folks who give someone else drugs and then someone overdoses or dies from that, the intent being to target the drug dealer. However, in reality, oftentimes people who are giving someone else drugs are using drugs themselves. And so sometimes we see this back and forth between are we using harm reduction in treatment?

11:07Are we using law enforcement and punitive measures? We're speaking to Aneri Patani, senior correspondent at KFF Health News, covering mental health and addiction. Also with us, Nabarun Dasgupta, a street drug scientist at the University of North Carolina, and Kaylee McLloyd, the director of Philadelphia's city-run overdose response unit. Nabarun, I just want to circle back to this demographic question, because suburban white people, people in rural areas, that became the face of the opioid epidemic. But was there always a silent crisis present in other communities that just went overlooked? Yes, absolutely.

11:48The majority of overdose deaths over the last three decades happened in urban or slightly urban areas. The storyline of the rural problems was really important because the number of deaths was high relative to the populations in those areas. And this was not uniformly done with all rural areas. For example, those rates are actually still very high in Native American reservations and Native American areas that are exceptionally rural. So the narrative has shifted, but the bulk of overdose deaths are really still happening in urban and suburban areas. Let's go back to our voicemail box. I am a recovering opiate addict.

12:34I have been undercover for about five years. When I decided to get help, I was around a group of people and there was a definite shift in the group conscious as spent all started flooding the streets and it scared me straight. I ended up using the methadone clinic to get off the opioids and then taper down to where I was off the methadone. And it worked great for me. And I've lost friends or people that I knew through the fentanyl crisis. And I'm just glad to be on the other side of it. Thanks for leaving that message. Now, Kaylee, we heard that person refer to fentanyl flooding the streets. And fentanyl has been driving overdose deaths around the country since around 2013.

13:15How are we seeing the types of drugs in this epidemic change over the years? Sure, absolutely. And I think that that's one of the things that's really important, that what was driving so much of this huge increase in fatal overdose that we saw is not necessarily that more people were using drugs, right? It's really down to what we're seeing in the drug supply and how different that is and how fast it changed. So you're right. We did start to see fentanyl in around 2013, specifically in Philadelphia. And that's when we really started to see overdose rates really, really rising. And that continued until recently.

13:59In the city of Philadelphia, what we started to see right after fentanyl was the inclusion of xylosine in the drug supply, which is a veterinary tool that is actually not safe for human consumption. And what that does is even though it's not a sedative, it really added sedative qualities. And so that's when you started to see people really in sort of this state where it is harder to revive. When we were thinking about reviving an overdose with naloxone, Even though xylazine is not an opioid, we know that most of the time xylazine is used in conjunction with an opioid. And so naloxone then remains the best practice.

14:44And now what we're seeing is actually a decrease in xylazine in the drug supply in Philadelphia, and that's being replaced with something called metatomidine. Now, Barun, I'd love to get your thoughts on this because this is something your lab examines, what's actually in the street drugs. What are you finding in your research? So we're seeing the street drug supply really shift on the East Coast and throughout kind of the center part of the country. Similar to xylosine on the West Coast, they've had a class of other additives with the fentanyl known as benzodiazepines. And so Xanax is the most common kind that people might have heard of, but there are more potent versions that are also sedatives.

15:25And so you see kind of a similar addition of sedatives in different parts of the country. With xylazine specifically, our lab has been able to identify that it is spreading and is being replaced, as we just heard, with metatomidine. But we're also seeing that xylazine is actually an atypical kind of opioid and has opioid properties as well. And so this all becomes important because what we are seeing is an adulterated drug supply where the sedative effects are so strong that people who use drugs are deciding to not continue use because the feelings that they get are not what they wanted and are also incapacitated enough of the day that they are choosing to not use because they want to have more functional capability.

16:18Let's head to a quick break. Still to come, the Trump administration makes big changes to mental health and drug programs. What these cuts could mean for combating the opioid epidemic. That's just ahead.

16:33Let's get back to our conversation with these messages we got from some of you. New Hampshire has adopted many harm reduction principles to combat substance use disorder. syringe service programs, legalized fentanyl test strips, expanded access to naloxone, and expanded peer recovery support service programs. These efforts have dropped death rates by 12 % from 2022 to 2023, but this epidemic is still here and alive, and we can't take our foot off the gas. Cheryl in New Hampshire, thanks for that message. Kaylee, how has Philadelphia approached harm reduction? Sure. So I think in the city of Philadelphia, it's really important that we emphasize the entire continuum of care, right?

17:26So there's harm reduction, which we really support through Narcan distribution. We're really excited that in the next few months, we are going to have naloxone access in over 60 different locations in the city of Philadelphia. And that means every single neighborhood. And then that also means in terms of our continuum, we want to make sure that treatment is available to anybody whenever they need it and that we have recovery support resources throughout the continuum. And I think the caller was exactly right. The gains that we've had in and the decrease in fatal overdose are fantastic. And it is not the time to take our foot off the gas.

18:09So that's something that I would emphasize, that now is the time to continue doing all the work to expand our continuum and make sure that these resources are really available for everybody that needs them when they need them. Kaylee, before we let you go, other than money, what other resources would be most helpful in helping Philadelphia further reduce both the need for addiction services, but also continue to reduce the number of overdose deaths? Sure. I think that empathy, empathy is incredibly important. I think that as a community, the city of Philadelphia has done a really great job of understanding that something like gun violence is all of our problem, right?

18:57And I think that we need that when we think about overdose and people who use drugs, that these are our people in our community. It's not the person over there. It's not a person that doesn't look like you. It's not a person that doesn't live in your neighborhood. And so I think that even if you don't understand addiction and substance use disorder specifically, you understand pain, you understand shame, and you understand the need to use something to cope. And so I think if we can just carry that empathy with us, it's really going to take us a long way. Well, that's Kaylee McLeod. She's the director of Philadelphia's city-run overdose response unit.

19:35Kaylee, thanks for speaking with us. Thanks so much. Now, everyone, I want to circle back to this question of prevention. We heard from a listener a little earlier about the need to basically get involved with young people, give them access to programs around science or sports, things that basically keep their time full and give them something to focus on. What does the research tell us about the efficacy of early intervention? So primary prevention is really going to be the way we get ourselves out of this crisis on a generational level. And when we were looking at the data last month, one of the things that struck us that was surprising was that there was a small, narrow group of folks whose death rate actually increased between 2022 and 2024.

20:25And those were kids who were born 2005 to 2011. So these are kids who would have been in middle school and early high school during the COVID disruptions. And those are the only groups that increased across the entire lifespan. So we need to do better with our education. What we have is the proof is kind of in the pudding here where the just say no and dare kind of curriculum era. Those kids who had those educations are going to be now in Gen X and in the millennial groups. And those are the groups that have the highest rates of drug overdose death in the country in the history of the country.

21:09So we need better education because the traditional models we have to help kids prevent drug use and drug use problems aren't really effective. Aniri, what sort of programs and funding did the Biden administration specifically put in place to combat the opioid epidemic? So a number of things. I mean, the federal government pays for lots of stuff around addiction and mental health. One of the big things since we're talking about prevention was actually what was considered the gun legislation from the Biden era. But really, it was this huge influx of funding for schools to set up mental health programs to look at how do we teach kids how to process their emotions, communicate with one another, be resilient.

21:55all these things that don't have the word, you know, drug or addiction in the title, but are skills that help students learn how to process mental health and can help prevent things like addiction or suicide or these various kind of crises we're dealing with in our country, the prevention can actually be the same. So that influx of cash from the Biden administration was one of the huge things on the prevention end. And so what types of cuts are we seeing the Trump administration make so far? A lot. It's kind of hard to get your hands around all the different cuts and the proposed cuts. One big one was kind of early on in, I'd say, mid to late March, the Trump administration cut more than$11 billion in what they considered COVID-era money.

22:45Some of that was specific to COVID, but a lot of it had been invested by states into mental health and substance use programs. And so a lot of those were what's called peer recovery programs, so run by folks who are in recovery themselves from addiction. I spoke with one program in Colorado. It's run by a woman named Raquel Garcia. It's called Hard Beauty. So Raquel is a mom who's in recovery herself. And she started this organization to help care for pregnant women with substance use disorders all across Colorado. So she employs other women who are in recovery, giving them a job and a meaningful way to contribute and maintain their recovery.

23:24And those women show up at the bedside for other women who are pregnant when they give birth. They help connect those moms to addiction treatment or housing, help them navigate child services. So all these really critical things. And when the Trump administration cut that funding, she wasn't sure that she could pay her employees anymore. And so she wasn't sure if they could show up at the bedside when the next woman gives birth. The administration is also eyeing billions of dollars of cuts for agencies responding to the fentanyl crisis specifically. What other funding could be on the chopping block?

23:56So the one you mentioned, you know, big cuts to SAMHSA, which is the Substance Abuse and Mental Health Services Administration. As the name suggests, they do a ton of heavy lifting around addiction and mental health. There are proposed cuts to grants that are given to first responders to access naloxone and train them on using it. Congress is considering big cuts to Medicaid, which is the largest payer for all sorts of mental health and addiction treatment in our country. So depending on those cuts, millions of people could lose access to health care, access to addiction treatment, access to counseling or other mental health supports.

24:41So there's a lot of uncertainty on the table. It's not all finalized. Congress still has to do its thing with the budget. But I think folks are wary because as soon as you introduce uncertainty, some of the programs, you know, staff start leaving. Or if they're not sure they can pay the staff, they have to cut down on services. So we're already starting to see some of this impact, even though all the cuts are not final. Now, Barun, as you hear both what's already been cut and what could be cut, what's most concerning to you? I think exactly what Aneri just said of we're losing our last mile capability.

25:17There's a lot of the outreach workers, the folks who are doing the frontline work. Those are jobs that are specialized and important and are not ones that are easily replaced. Those are folks who have connections to their communities. and that's where we need to retain and train and build up that workforce. I think that's what I'm really concerned about. So what I hear you saying, and correct me if I'm wrong, is that the changes at the federal level in support could turn into less support for work happening within local communities. What could fill that vacuum? Are we seeing anyone step up? I mean, the opioid settlement funds are there kind of for this reason and it's a natural way to plug those gaps.

26:01But the settlements are front-loaded and they're not long-term sustainable funding for hiring a lot of folks. And those are the skills that I think we're going to be rapidly losing. We're already seeing massive layoffs in smaller programs in Appalachia that really should be the ones that we're promoting more. Valerie emails, after a horrific car accident, I was prescribed opioids. It took me a long time to stop taking them as it was early days in the epidemic. I haven't had any in over 10 years and have left doctor's offices where they prescribed opiates and sleeping pills. As far as the Sacklers are concerned, their penance should be working every week in clinic serving and caring for all the people who have suffered for their wealth.

26:46Now, Aneri, you've been following the money on opioid settlement funds. Give us a quick refresher on where we are right now? Absolutely. So the Sackler family and Purdue Pharma are the best known, kind of, or most well-known, I should say, folks in this realm created OxyContin. They were sued for misleading folks about whether the pills were addictive or not. Just yesterday, there was news that states have agreed to sort of a new proposed settlement with Purdue Pharma and the Sacklers that's set to pay out$7.4 billion over 15 years. But that is still winding its way through courts. It needs approval.

27:25Meanwhile, there are other companies, more than a dozen, that have already started paying out opioid settlements to state and local governments that should total about$50 billion paid through 2038. So there's a lot of money that's been coming in. State and local governments are starting to spend them, and they have more coming. JJ sent us this email. My family has been affected by the opioid epidemic. I want to know why all the billions of penalties are not available to help pay for treatment. My wife and I have paid over$50 ,000 for rehabilitation and treatment costs for our family. Why can't families access financial help to pay for these costs?

28:03What can you tell us, Aneri? I hear this question all the time. There's so much frustration and confusion because when people hear opioid settlements, they assume, you know, the victims of the crisis, the individuals, the families are getting payouts. The reality is the vast majority of the settlement money is going to governments. There are a few companies, Purdue Pharma is one of them, that have a mechanism where individuals can apply to get some money. But most people are going to be getting, you know, a few hundreds to a few thousands, whereas the states and local governments are getting millions and billions.

28:39And the idea is that they are supposed to turn around and use it, invest in programs and services that would help individuals who are victims, who are still dealing with addiction with their families. But there has been a lot of contention around, you know, how are governments using this money? Is it actually helping the folks? And I think if you asked any given individual, they could give you, you know, five or ten different responses on how they think the states are doing with this money. Well, and number one, I'm curious about the research aspect of this. We've seen the Trump administration cut research funding.

29:12How is that shaping what scientists like you can learn about how to best treat and respond to this crisis? So right now, one of the ways that the research has been helping in the past is by making definitive statements like this is a better medication or this is the gold standard, most effective medication or tool or whatever prevention program. We're losing that. And what's filling the void in this moment of deregulation is an influx of corporate influence into healthcare decision-making, often targeted very aggressively at county commissioners and county health officials who are trying to find ways to spend the opioid settlement money.

29:55And so what we're already seeing is kind of a silencing of what are the effective scientifically proven standards and an influx of influence from corporate entities who aren't necessarily acting in the public's best interest but have a kind of one-sided corporate narrative to put out there. Well, that leads me back to what you called the hidden work. As the U.S. continues to combat the opioid crisis, what do you think are some key things for communities to continue to focus on, things that are working? So I think, absolutely, things are working right now. We are going to see spikes and we're going to see increases as things move forward.

30:39And so how we respond in those moments is going to be really critical. We have to kind of tamp down the background, but also be able to respond quickly. I think there are a lot of hidden populations as well. So pain patients who had been stable on their medications for a long time, their rates of suicide are really high and really depressing after being abruptly cut off. So I think part of the settlement funds really should be going to making sure that we have adequate pain management and then also kind of having prevention programs at the background level for the school kids, but really focusing on overdose prevention at the kind of midlife, people who are in middle age at this current time.

31:26Aneri, what are you watching either at the federal level or around what happens with these settlement funds? I think they're tied together. As we see a lot of federal cuts, potential cuts coming down the pike, there are states and local governments trying to plug those gaps with opioid settlement funds. But I think it's not enough money. It's not going to make up for the federal gap. And there are concerns that the opioid settlement was supposed to be adding additional resources, not just keeping us where we are. So I think there's a lot to watch on both of those fronts. That's Aneri Patani. She's a senior correspondent at KFF Health News covering mental health and addiction.

31:59Also with us, Nabaroon Dasgupta, a street drug scientist at the University of North Carolina with two decades of experience in overdose prevention. He's also the co-founder of Remedy Alliance for the People. That organization ensures harm reduction programs have access to low-cost naloxone. Nabaroon, Aneri, thank you for speaking with us. Today's producer was Michelle Harvin. This program comes to you from WAMU, part of American University in Washington, distributed by NPR. I'm Jen White. Thanks for listening. Thanks for sharing your stories with us. We'll talk again tomorrow. This is 1A.

32:50Thank you.

From the publisher
Drug overdose deaths have been increasing steadily for over two decades in large part due to opioids. That's until recently. Now, new data from the Centers for Disease Control found that 2024 saw the largest one year decline ever recorded. And that 24% decline was felt across the country. Every state except two saw a drop in overdose deaths.

The drop comes after an aggressive public health response from both the Biden Administration and local efforts, including making the overdose reversing drug Naloxone available over the counter and in communities. But the crisis is far from over. Drug overdoses are still the leading cause of death for people aged 18 to 44.

We discuss what we can we learn from looking at the recent decline in drug deaths and what federal cuts could mean for that progress.

Want to support 1A? Give to your local public radio station and subscribe to this podcast. Have questions? Connect with us. Listen to 1A sponsor-free by signing up for 1A+ at plus.npr.org/the1a.

Learn more about sponsor message choices: podcastchoices.com/adchoices

NPR Privacy Policy

More from 1A

All episodes